-
EC approves Astellas’ Xtandi for high-risk prostate cancer treatment
24 Apr 2024 11:23 GMT
… BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are not … network of dedicated clinical trial investigators, patient groups, clinical trial participants and their … early, recurrent hormone-sensitive prostate cancer setting. Astellas is in …
-
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.
24 Apr 2024 08:24 GMT
… of patients with castrate-resistant prostate cancer at high risk of developing … Ng, Henry H Woo
San Clinical Trial Unit, Sydney Adventist Hospital, Integrated …
-
Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.
24 Apr 2024 08:24 GMT
… prostatectomy (RP) in managing oligometastatic prostate cancer (omPCa) [1]. They analyzed the … not be recommended outside of clinical trials.
Prostate cancer and prostatic diseases. 2024 Apr …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… global network of dedicated clinical trial investigators, patient groups, clinical trial participants and their … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies.
23 Apr 2024 11:53 GMT
… PRAD) to neuroendocrine prostate cancer (NEPC)--a … prostate cancer, we applied single cell analyses to 21 human prostate tumor … clinical trials, potentially across distinct cancer types.
Treatment of prostate cancer … and neuroendocrine prostate cancer. We show …
-
Inside J&J’s strategy to de-gender clinical trials
23 Apr 2024 11:24 GMT
… Men with prostate cancer” is a common phrase in clinical trial protocols for prostate cancer treatments. … diversity, equity and inclusion in clinical trials at Johnson & Johnson … comfortable and safe participating in clinical trials,” Wildgurst said.
To do …
-
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials
23 Apr 2024 04:01 GMT
… recurrence of prostate cancer after radical prostatectomy or radiation therapy.
These clinical trials are … .com or contact Curium’s Clinical Trial team directly at solar@curiumpharma … questions or to locate a clinical trial site near you. About Curium …
-
What Patients Can Do as Racial Disparities Persist in Prostate Cancer
23 Apr 2024 00:57 GMT
… clinical trials due to lack of awareness, lack of diversity in clinical trial … in clinical trials is a huge area where we, as a prostate cancer … if there is a clinical trial they may be eligible … less able to generalize our clinical trial findings if we don…
-
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
22 Apr 2024 12:47 GMT
… Surveillance (AS) for prostate cancer, the Decipher Prostate … study of the ENACT clinical trial (NCT02799745) that aimed … advance scientific understanding of prostate cancer. Specifically, the researchers … -transcriptome data for prostate cancer samples to gain …
-
New Study Shows Veracyte's Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
22 Apr 2024 12:44 GMT
… Surveillance (AS) for prostate cancer, the Decipher Prostate … study of the ENACT clinical trial (NCT02799745) that aimed … advance scientific understanding of prostate cancer. Specifically, the researchers … -transcriptome data for prostate cancer samples to gain …